[1]
L. C. Ortigosa, L. C. Silva, A. J. Duarte, M. D. Takahashi, and G. Benard, “Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis”, Acta Derm Venereol, vol. 94, no. 1, pp. 26–31, Jul. 2013.